R. Salgia
Division of Hematologic Malignancies
Dana-Farber Cancer Institute and Harvard Medical School
Boston
Massachusetts 02115
USA
Name/email consistency: high
- The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha. Salgia, R., Quackenbush, E., Lin, J., Souchkova, N., Sattler, M., Ewaniuk, D.S., Klucher, K.M., Daley, G.Q., Kraeft, S.K., Sackstein, R., Alyea, E.P., von Andrian, U.H., Chen, L.B., Gutierrez-Ramos, J.C., Pendergast, A.M., Griffin, J.D. Blood (1999)
- Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma. Salgia, R., Hedges, T.R., Rizk, M., Reimer, R.H., Skarin, A.T. Lung. Cancer (1998)
- Molecular abnormalities in lung cancer. Salgia, R., Skarin, A.T. J. Clin. Oncol. (1998)
- BCR/ABL induces multiple abnormalities of cytoskeletal function. Salgia, R., Li, J.L., Ewaniuk, D.S., Pear, W., Pisick, E., Burky, S.A., Ernst, T., Sattler, M., Chen, L.B., Griffin, J.D. J. Clin. Invest. (1997)